EUVIMEDEUVIMED entdecken
Crossref

Prenatal Diagnosis of 22q11.2 Deletion Syndrome Using Fluorescence In Situ Hybridization (FISH)

P. K. Gadhia, Salil Vaniawala

Annals of Child Health · 11.03.2026 · 2 · 79-81

DOI: 10.25259/ach_15_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Child Health, online erschienen am 11.03.2026. Verfasst von P. K. Gadhia und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

22q11.2 deletion syndrome (22q11.2DS), also known as DiGeorge or velocardiofacial syndrome, is the most common chromosomal microdeletion disorder in humans. Prenatal detection is critical for pregnancy management, as affected individuals may present with congenital heart defects, immune dysfunction, craniofacial anomalies, developmental delay, and neuropsychiatric disorders. Material and Methods: A retrospective study was conducted from January 21 to June 24 on 70 pregnancies with suspected congenital structural heart defects. Fluorescence in situ hybridization (FISH) analysis was performed on amniotic fluid samples using a DiGeorge syndrome specific probe targeting the 22q11.2 region, following the manufacturer’s instructions. At least, 30 interphase nuclei were evaluated per case.

Results

Conventional cytogenetic analysis revealed normal karyotypes in all 70 cases. However, FISH analysis detected 22q11.2 microdeletions in 3 cases (4.3%). These findings align with previous reports indicating a significant association between conotruncal cardiac anomalies and 22q11.2 deletions.

Conclusion

FISH is a rapid, specific, and reliable technique for the prenatal detection of 22q11.2DS, particularly in pregnancies at risk. While it does not provide information on deletion size or detect other chromosomal abnormalities, it remains an invaluable diagnostic tool when combined with comprehensive genetic counseling. Early identification enables timely medical planning and psychosocial support, ultimately improving perinatal outcomes.

Zitieren

APA

Gadhia, P. K., & Vaniawala, S. (2026). Prenatal Diagnosis of 22q11.2 Deletion Syndrome Using Fluorescence In Situ Hybridization (FISH). Annals of Child Health, 2, 79-81. https://doi.org/10.25259/ach_15_2025

Vancouver

Gadhia PK, Vaniawala S. Prenatal Diagnosis of 22q11.2 Deletion Syndrome Using Fluorescence In Situ Hybridization (FISH). Annals of Child Health. 2026;2:79-81. doi:10.25259/ach_15_2025

BibTeX
@article{Gadhia2026,
  author = {Gadhia, P. K. and Vaniawala, Salil},
  title = {Prenatal Diagnosis of 22q11.2 Deletion Syndrome Using Fluorescence In Situ Hybridization (FISH)},
  journal = {Annals of Child Health},
  year = {2026},
  volume = {2},
  pages = {79--81},
  doi = {10.25259/ach_15_2025}
}
Kostenlos starten →